Combined Modality TherapyRadiotherapyRadiotherapy DosageMechlorethamineProcarbazineRadiotherapy, AdjuvantRadiotherapy, ConformalHodgkin DiseaseAntineoplastic Combined Chemotherapy ProtocolsLomustineVincristineRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyPrednisoneNeoplasm StagingActuarial AnalysisLung NeoplasmsTreatment OutcomeDose FractionationRadiation InjuriesSurvival AnalysisRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedCarcinoma, Small CellCisplatinPrognosisDisease-Free SurvivalSurvival RateChemotherapy, AdjuvantCyclophosphamideFollow-Up StudiesDoxorubicinFluorouracilAdenocarcinomaRadiation OncologyCarcinoma, Non-Small-Cell LungClinical Trials as TopicRadiosurgeryBrachytherapyDose-Response Relationship, RadiationHead and Neck NeoplasmsNeoplasm Recurrence, LocalChemoradiotherapyRetrospective StudiesBrain NeoplasmsNasopharyngeal NeoplasmsCarcinoma, Squamous CellRadiation ToleranceOrgans at RiskRadiation-Sensitizing AgentsTomography, X-Ray ComputedRectal NeoplasmsParticle AcceleratorsCranial IrradiationRadiometryProstatic NeoplasmsRadiation DosageRadiation PneumonitisBreast NeoplasmsPelvic NeoplasmsTime FactorsLaryngeal NeoplasmsHeavy Ion RadiotherapyMastectomy, SegmentalNeoplasmsNeoplasms, Radiation-InducedNeoplasms, Second PrimaryRadiodermatitisAntineoplastic AgentsDacarbazineOrgan Sparing TreatmentsNeoadjuvant TherapyXerostomiaMagnetic Resonance ImagingRadioisotope TeletherapySpinal NeoplasmsPositron-Emission TomographyPalliative CareCarcinomaProspective StudiesGlioblastomaCobalt RadioisotopesUterine Cervical NeoplasmsLymphatic IrradiationKaplan-Meier EstimateRadiopharmaceuticalsRadiation-Protective AgentsSalvage TherapyEsophageal NeoplasmsFeasibility StudiesGliomaPelvisBleomycinLymphatic MetastasisMastectomyThoracic NeoplasmsOsteoradionecrosisAntineoplastic Agents, AlkylatingTumor Burden